Systematixgroup and 6 other SEBI-registered analysts issued 12 positional recommendations across 9 stocks for trend-following positions, with a bullish bias.
Systematixgroup and 6 other SEBI-registered analysts issued 12 equity positional recommendations today, designed for positional traders riding medium-term trends. The batch carries a bullish bias — 12 buys against 0 sells — covering 9 stocks.
The 5 most-covered names of the session:
AARTIPHARM attracted 2 buys from Aalgobreaths (SEBI Reg. INH000019886) at ₹1,010 targeting ₹1,020 and ₹1,040 (stop ₹990).
CENTUM attracted 2 buys from Investmltd (SEBI Reg. INH000010742) at ₹4,370 targeting ₹4,747 and ₹4,989 (stop ₹4,124).
JKLAKSHMI attracted 2 buys from Systematixgroup (SEBI Reg. INH200000840) at ₹500 targeting ₹548 and ₹588 (stop ₹454).
CYIENT was flagged for a buy by WealthFino (SEBI Reg. INH300009914) at ₹1,079.4, targeting ₹1,070 — a potential upside of -0.9%.
ECLERX was flagged for a buy by Jainamresearch (SEBI Reg. INH000006448) at ₹1,557, targeting ₹286 — a potential upside of -81.6%, with a stoploss at ₹1,516. The risk-to-reward ratio stands at 1:31.0.
The remaining 4 stocks covered by SEBI-registered analysts, with the price at which each call was issued:
Buy calls — INDUSTOWER (₹394 → ₹432) via Systematixgroup; MAXHEALTH (₹950.5 → ₹968) via Jainamresearch; MOL (₹1,529.9 → ₹1,610.4) via Motilaloswalofficial; RADICO (₹4,641 → ₹4,840) via Prudentbroking.
This roundup reproduces calls from 7 SEBI-registered Research Analysts: Systematixgroup (SEBI Reg. INH200000840); Aalgobreaths (SEBI Reg. INH000019886); Investmltd (SEBI Reg. INH000010742); Jainamresearch (SEBI Reg. INH000006448); Motilaloswalofficial (SEBI Reg. INH000000412); Prudentbroking (SEBI Reg. INH000018115); WealthFino (SEBI Reg. INH300009914).
Positional trades are trend-following in nature. Trail stoplosses as the trade moves in your favour and avoid averaging down against the trend.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.